Immunome Balance Sheet Health
Financial Health criteria checks 6/6
Immunome has a total shareholder equity of $119.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $148.5M and $28.7M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$142.15m |
| Equity | US$119.88m |
| Total liabilities | US$28.66m |
| Total assets | US$148.54m |
Recent financial health updates
Will Immunome (NASDAQ:IMNM) Spend Its Cash Wisely?
Mar 17
Is Immunome (NASDAQ:IMNM) In A Good Position To Deliver On Growth Plans?
Nov 20Here's Why We're Watching Immunome's (NASDAQ:IMNM) Cash Burn Situation
Aug 05We Think Immunome (NASDAQ:IMNM) Can Afford To Drive Business Growth
Feb 21Companies Like Immunome (NASDAQ:IMNM) Are In A Position To Invest In Growth
Oct 02Recent updates
Immunome: Why It Has Doubled Over The Last Month
Jan 18Will Immunome (NASDAQ:IMNM) Spend Its Cash Wisely?
Mar 17Is Immunome (NASDAQ:IMNM) In A Good Position To Deliver On Growth Plans?
Nov 20Immunome GAAP EPS of -$0.74
Aug 05Here's Why We're Watching Immunome's (NASDAQ:IMNM) Cash Burn Situation
Aug 05Immunome gains 34% after preclinical data on COVID-19 antibody
Jun 30We Think Immunome (NASDAQ:IMNM) Can Afford To Drive Business Growth
Feb 21Companies Like Immunome (NASDAQ:IMNM) Are In A Position To Invest In Growth
Oct 02Immunome launches $27M private placement
Apr 26Do Institutions Own Immunome, Inc. (NASDAQ:IMNM) Shares?
Mar 12Read This Before Selling Immunome, Inc. (NASDAQ:IMNM) Shares
Jan 18Immunome EPS misses by $7.22
Nov 17Financial Position Analysis
Short Term Liabilities: IMNM's short term assets ($144.7M) exceed its short term liabilities ($21.8M).
Long Term Liabilities: IMNM's short term assets ($144.7M) exceed its long term liabilities ($6.8M).
Debt to Equity History and Analysis
Debt Level: IMNM is debt free.
Reducing Debt: IMNM has no debt compared to 5 years ago when its debt to equity ratio was 23.8%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: IMNM has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: IMNM has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 1.9% each year